Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Vets give fresh hope to children with severe epilepsy
The miniature wirehaired dachshund is particularly susceptible to Lafora.

Study findings will help shape treatment for Lafora disease

A new study led by vets is giving fresh hope to children suffering from a severe form of epilepsy.

The research, published in PLOS ONE, set out to identify the progression of Lafora disease - a rare and inherited condition that affects some 50 youngsters worldwide.

Dogs can also contract Lafora disease, so vets assessed affected canines to better understand the disease and help develop an effective treatment.

The research was conducted by the University of Surrey's School of Veterinary Medicine in collaboration with Fitzpatrick Referrals, Surrey.

In the study, researchers surveyed the owners of 27 miniature wirehaired dachshund - a dog breed that is particularly susceptible to Lafora. The survey was carried out over the course of 12 months to detect the clinical signs and physical advancement of the condition.

Researchers found the most common signs of Lafora were reflex and spontaneous muscle contractions (77.8%), uncontrollable jerks (51.9%), and generalised seizures (40.7%). Less commons signs were ‘facial seizure’, ‘jaw smacking’, ‘fly catching’, ‘panic attacks’, and ‘aggression’.

The team hopes that their findings will help shape the development of a treatment for this disease, of which there is currently no cure.

“Lafora disease is a fatal disease that causes unbearable suffering for dogs and in rare cases young children,” commented Dr Clare Rusbridge, reader in veterinary neurology at the University of Surrey and chief neurologist at Fitzpatrick Referrals.

“Due to its rarity, little is known about the onset of this illness but what we have discovered, with the help of dog owners, is the clinical sign of Lafora helping to lead to quicker diagnosis. The more we learn about Lafora, the better chance we have of treating it effectively.”

Lafora disease is caused by a genetic mutation which leads to the build-up of glycogen in the body. This build-up affects the nervous system, leading to progressive seizures, loss of walking ability and dementia.

The discovery of the canine Lafora genetic mutation occurred in 2005 following a pioneering collaboration between Dr Rusbridge and The Hospital for Sick Children in Toronto. Thanks to increased awareness and testing, the number of litters bred with a risk of Lafora disease has fallen from 55 per cent to less than five per cent in just five years. 

Become a member or log in to add this story to your CPD history

RCVS Knowledge appoints Veterinary Evidence editor-in-chief

News Story 1
 RCVS Knowledge has welcomed Professor Peter Cockcroft as editor-in-chief for Veterinary Evidence.

A world-renowned expert in evidence-based veterinary medicine, Prof Cockcroft will lead the strategic development and editorial quality of the open-access journal. He was previously in the role from 2017-2020.

Katie Mantell, CEO of RCVS Knowledge, said: "We are excited about the extensive knowledge of evidence-based veterinary medicine and clinical veterinary research that Peter brings, and we look forward to working with him over this next phase of the journal's development." 

Click here for more...
News Shorts
Defra to host bluetongue webinar for vets

The Department for Environment, Food and Rural Affairs (Defra) will be hosting a webinar for veterinary professional on bluetongue on Thursday, 25 April 2024.

Topics covered will include the transmission cycle, pathology and pathogenesis, clinical signs (including signs seen in recent BTV-3 cases in the Netherlands), and control and prevention.

The session, which will take place from 6pm to 7.30pm, is part of Defra's 'Plan, Prevent and Protect' webinar series, which are hosted by policy officials, epidemiologists and veterinary professionals from Defra and the Animal and Plant Health Agency. The bluetongue session will also feature insights from experts from The Pirbright Institute.

Those attending will have the opportunity to ask questions. Places on the webinar can be booked online.